TrialJournal of virology2009

Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.

Yo Hoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.